RapidAI Added Riverain Chest Imaging AI
The integration brings vessel and bone suppression tools to over 2,500 hospitals in the RapidAI network.
Updated on Oct. 6, 2026 in Software
Live Poll
Do you trust artificial intelligence tools to accurately analyze medical scans for potential health issues?
RapidAI has integrated Riverain Technologies' ClearRead Chest AI into its enterprise platform. The software, which is now available to 2,500 hospitals, performs automated analysis of chest X-rays and CT scans.
Why it matters
This integration expands the clinical utility of the Rapid Enterprise Platform by embedding diagnostic-grade AI directly into existing radiology workflows. It provides immediate access to specialized lung and heart imaging analysis tools for a large, established global hospital base.
ClearRead Chest utilizes vessel and bone suppression algorithms to analyze CT scans and X-rays for pulmonary nodules, pneumothoraces, and coronary artery calcification. The suite functions within the RapidAI environment alongside the Rapid Edge Cloud and Navigator Pro systems.
The players
Riverain Technologies
A medical software company focused on AI-driven diagnostic tools for chest imaging and tissue suppression.
RapidAI
A developer of clinical decision-support and workflow software for neurovascular and vascular care with a global hospital footprint.
The details
The software functions by isolating anatomical structures to enhance the visibility of potential pathologies. By utilizing vessel and bone suppression—a technique that digitally removes obstructing tissue from imaging data—the system allows radiologists to more clearly identify small abnormalities. This module is now accessible via the Rapid Enterprise Platform, connecting directly to current mobile and web-based radiology workflows.
Timeline
October 6, 2026: The ClearRead Chest integration was officially announced.
The Tech Race
This integration follows the pattern set by the expansion of the RapidAI Rapid Enterprise Platform, which consolidates multiple clinical AI tools into a single radiology interface. The move highlights the industry-wide push to centralize diagnostic AI into established hospital infrastructure.
Clinicians within the 2,500 hospitals in the RapidAI network can now access ClearRead Chest tools through their existing mobile and web interfaces. No additional software installation is required for current users, though workflow updates may vary by hospital policy.
The takeaway
The deployment demonstrates a shift toward bundled clinical AI applications within existing enterprise portals. Watch for further platform updates as RapidAI continues to incorporate specialized diagnostic modules into its cloud infrastructure.
Further reading
For more developments in medical imaging automation, see our latest coverage on Software.
Source note: This article includes information reported by AuntMinnie.
Live Poll
Do you trust artificial intelligence tools to accurately analyze medical scans for potential health issues?
